Using of herbal mucolytics in the complex therapy of acute and chronic rhinosinusitis

Author:

Selezneva L. V.1ORCID,Vartanyan K. G.1ORCID

Affiliation:

1. Sechenov First Moscow State Medical University (Sechenov University)

Abstract

Chronic rhinosinusitis is a polyetiological heterogeneous disease that is characterized by inflammation of the nasal mucosa and paranasal sinuses. The clinical picture of this pathology may include nasal congestion and rhinorrhea. Studies on the pathogenesis of chronic rhinosinusitis have yielded insufficient results, however, a number of factors that predispose to the development of this disease are currently identified according to clinical guidelines. Among these are both anatomical anomalies and some chronic diseases (rhinitis, atopy), immune system disorders (immunodeficiencies), etc. Mucoactive drugs are used in the treatment of acute and chronic rhinosinusitis to restore the transport function of the upper respiratory tract epithelium. Their mechanism of action is aimed at restoring mucociliary clearance. This therapy also affects the viscous discharge, which is produced during rhinosinusitis and accumulates in the paranasal sinuses and nasal cavity, worsening the course of the inflammatory process. Specialists distinguish the following forms of mucoactive drugs: mucolytics, mucokinetics and mucoregulators. The article considers the aspects of the clinical use of herbal mucolytics for the treatment of acute and chronic rhinosinusitis, in the pathogenesis of which the nasal mucosa edema plays a key role. The authors summarise the most conclusive evidence to date on the need to use herbal mucolytics in the complex therapy of acute and chronic rhinosinusitis. The modern topical therapy of acute and chronic rhinosinusitis in the otorhinolaryngology practice is presented. Herbal medicinal products have a proven secretolytic and anti-inflammatory effect, accelerate the relief of symptoms and reduce the recovery time of patients. The clinical guidelines recommend to prescribe these drugs in addition to the complex therapy of rhinosinusitis to patients suffering from ARS and CRS, who has no contraindications.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference40 articles.

1. Palchun V.T. (ed.). Otorhinolaryngology: national guide. Moscow: GEOTARMedia; 2008. 954 p. (In Russ.)

2. Garbutt J.M., Banister C., Spitznagel E., Piccirillo J.F. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA. 2012;307(7):685–692. https://doi.org/10.1001/jama.2012.138.

3. Yakovlev V.P., Yakovlev S.V. (eds.). Rational antimicrobial pharmacotherapy. Moscow; 2003. 1008 р. (In Russ.)

4. Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(29 Suppl.):1–464. https://doi.org/10.4193/rhin20.600.

5. Krukov A.I., Turovskiy A.B. Antibacterial therapy of acute medium otitis and sinusitis in adults in outpatient practice. RMJ. 2004;(21):1188–1191. (In Russ.) Available at: https://www.rmj.ru/articles/obshchie-stati/Antibakterialynaya_terapiya_ostrogo_srednego_otita_i_sinusita_u_vzroslyh_v_ambulatornoy_praktike.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3